34048275Pollard JA, Guest E, Alonzo TA, Gerbing RB, Loken MR, Brodersen LE, Kolb EA, Aplenc R, Meshinchi S, Raimondi SC, Hirsch B, Gamis ASJournal of clinical oncology : official journal of the American Society of Clinical OncologyAntineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Gemtuzumab; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia ProteinAdolescent; Anthracyclines; Child; Child, Preschool; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Progression-Free Survival; Recurrence; Risk Assessment; Risk Factors; Time Factors; United StatesPollard JA, Guest E, Alonzo TA, Gerbing RB, Loken MR, Brodersen LE, Kolb EA, Aplenc R, Meshinchi S, Raimondi SC, Hirsch B, Gamis AS. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531. J Clin Oncol. 2021 10 01; 39(28):3149-3160.J Clin Oncol2021-05-28T00:00:002021Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531.cmhprofilesont:personsuffixperson suffixprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD008297Physiology11633280.54802MaleD011495Chemicals & Drugs6100.9893Histone-Lysine N-MethyltransferaseD012008Phenomena331230.961622RecurrenceD012307Concepts & Ideas834700.875967Risk FactorsD013997Concepts & Ideas612470.920232Time FactorsD014408Chemicals & Drugs18630.953706Biomarkers, TumorD014481Geographic Areas846560.814989United StatesD015321Physiology680.988119Gene RearrangementD015470Disorders81140.899415Leukemia, Myeloid, AcuteD018380Procedures19510.929369Hematopoietic Stem Cell TransplantationD018570Concepts & IdeasProcedures541370.942324Risk AssessmentD018943Chemicals & Drugs470.992941AnthracyclinesMD, MPHAlanGamisAlan S. Gamis0.000000000000000.0000000000000049Gamis, Alan0000-0003-1513-2893Chief, Section of OncologyD051788Chemicals & Drugs270.988561Myeloid-Lymphoid Leukemia ProteinMDErinGuestErin M. Guest0.000000000000000.00000000000000150Guest, Erin0000-0003-2482-5608Hematology/Oncology PediatricianD000293Living Beings10621370.61882AdolescentPediatricsResearchClinicalChildren's Mercy Kansas CityD000971Procedures14710.937832Antineoplastic Combined Chemotherapy ProtocolsAuthorship 9696120.8221390.2055352authors10.2522has subject areaAuthorship 99452true1Chief, Section of OncologyChief, Section of Oncologytrue1Hematology/Oncology PediatricianHematology/Oncology PediatricianD002648Living Beings11632570.520082ChildD002675Living Beings10415030.693171Child, PreschoolD003561Chemicals & Drugs3240.983434CytarabineD005260Physiology11835990.534568FemaleD006801Living Beings12067970.397999HumansD007223Living Beings9914490.693714InfantD007231Living Beings858280.780221Infant, Newborn